Results 161 to 170 of about 229,203 (309)

New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis

open access: yesFrontiers in Immunology
Worldwide, most (80%–90%) hepatocellular carcinomas (HCCs) develop against a background of liver cirrhosis, where chronic inflammation, fibrosis, and immune dysfunction collectively shape an immunosuppressive hepatic microenvironment. Despite significant
Yufan Liu   +4 more
doaj   +1 more source

Hepatic manifestations of celiac disease

open access: yesClinical and Experimental Gastroenterology, 2010
Hugh James FreemanDepartment of Medicine (Gastroenterology), University of British Columbia, Vancouver, British Columbia, CanadaAbstract: Different hepatic and biliary tract disorders may occur with celiac disease.
Hugh James Freeman
doaj  

A bite difficult to heal: Pasteurella multocida induced decompensated hepatic cirrhosis. [PDF]

open access: yesJ Community Hosp Intern Med Perspect, 2021
Patel H, Patel N, Patel H, Chow RD.
europepmc   +1 more source

Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma. [PDF]

open access: yesInt J Immunopathol Pharmacol, 2022
Elghoroury EA   +9 more
europepmc   +1 more source

Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis. [PDF]

open access: yesIntern Med, 2021
Tatsumi R   +7 more
europepmc   +1 more source

Hepatic Encephalopathy Without Cirrhosis [PDF]

open access: yesAmerican Journal of Transplantation, 2013
L, Sibulesky   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy